Novavax shares dip 5% after Covid shots could be delayed



Novavax Inc. shares dipped in the premarket session on Thursday after it was learned that the United States Food and Drug Administration (FDA) could delay the approval of the Novavax’s COVID-19 va…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento